Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089596
Status:
COMPLETED
Last Update Posted:
2007-04-12
First Post:
2004-08-06
Brief Title:
Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Sponsor:
ViaCell
Organization:
ViaCell
Study Overview
Official Title:
A Safety Study of Infusion of Ex Vivo Selectively Amplified Unrelated Cord Blood Stem Cells in Subjects With Hematological Malignancies Receiving Unrelated Cord Blood Transplantation
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study hopes to show that specially treated umbilical cord cells called stem cells can be safely given to a person after they receive chemoradiation therapy or chemotherapy for their illness During chemoradiation therapy or chemotherapy a person loses all of the cells that are needed to make the different types of cells in their blood including their immune system cells These cells must be replaced in order for the blood and immune systems to work properly Some people receive bone marrow transplants or other types of stem cell transplants to get the cells they need CB001 is being developed as an option for people who need bone marrow transplants or other types of transplants to replace those cells It is also being developed for people who do not have the option of other types of transplants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None